1. Home
  2. BATRA vs RCUS Comparison

BATRA vs RCUS Comparison

Compare BATRA & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BATRA
  • RCUS
  • Stock Information
  • Founded
  • BATRA 1991
  • RCUS 2015
  • Country
  • BATRA United States
  • RCUS United States
  • Employees
  • BATRA N/A
  • RCUS N/A
  • Industry
  • BATRA Broadcasting
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BATRA Industrials
  • RCUS Health Care
  • Exchange
  • BATRA Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • BATRA 2.9B
  • RCUS 2.4B
  • IPO Year
  • BATRA N/A
  • RCUS 2018
  • Fundamental
  • Price
  • BATRA $42.60
  • RCUS $23.86
  • Analyst Decision
  • BATRA Strong Buy
  • RCUS Buy
  • Analyst Count
  • BATRA 3
  • RCUS 8
  • Target Price
  • BATRA $58.00
  • RCUS $27.63
  • AVG Volume (30 Days)
  • BATRA 65.1K
  • RCUS 2.0M
  • Earning Date
  • BATRA 11-05-2025
  • RCUS 10-28-2025
  • Dividend Yield
  • BATRA N/A
  • RCUS N/A
  • EPS Growth
  • BATRA N/A
  • RCUS N/A
  • EPS
  • BATRA N/A
  • RCUS N/A
  • Revenue
  • BATRA $723,307,000.00
  • RCUS $240,000,000.00
  • Revenue This Year
  • BATRA $14.16
  • RCUS N/A
  • Revenue Next Year
  • BATRA $3.97
  • RCUS N/A
  • P/E Ratio
  • BATRA N/A
  • RCUS N/A
  • Revenue Growth
  • BATRA 6.62
  • RCUS N/A
  • 52 Week Low
  • BATRA $38.67
  • RCUS $6.50
  • 52 Week High
  • BATRA $50.50
  • RCUS $24.95
  • Technical
  • Relative Strength Index (RSI)
  • BATRA 49.06
  • RCUS 81.70
  • Support Level
  • BATRA $42.06
  • RCUS $19.44
  • Resistance Level
  • BATRA $43.07
  • RCUS $20.85
  • Average True Range (ATR)
  • BATRA 0.66
  • RCUS 1.16
  • MACD
  • BATRA 0.10
  • RCUS 0.21
  • Stochastic Oscillator
  • BATRA 70.80
  • RCUS 87.59

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: